TGF-β is released from cancer cells and can increase the expansion of M-MDSCs (243), recruit suppressive cells to the TME (MDSCs, Tregs, DCs, and stromal cells), and compromise the function of NK cells (230, 244–246), cytotoxic CD8+ cells, DCs, Tregs, and macrophages (247). Here, CD8A is linked to cancer.